Churg-Strauss-Syndrome (CSS) often takes a mild course and is in many cases treated
successfully by glucocorticosteroids (GC) alone. However, there are also several reports …

Churg-Strauss syndrome (CSS) is a primary systemic vasculitis occurring primarily in
patients with asthma. Unlike other small vessel vasculitides, CSS is characterised by blood …

Churg-Strauss syndrome (CSS) is characterized by the presence of asthma, eosinophilia,
and small-vessel vasculitis with granuloma. It is a distinct entity, as determined from all …

Churg-Strauss syndrome (CSS) is a form of primary vasculitis characterized by allergy and
angiitis. In the organ systems involved (lung, heart, peripheral nervous system, and so forth) …

Abstract Churg–Strauss syndrome (CSS), alternatively known as eosinophilic
granulomatosis with polyangiitis (EGPA), was first described in 1951 by Churg and Strauss …

Background. Interferon-α has been successfully used for induction of remission in patients
with Churg-Strauss syndrome, but data on its ability to prevent relapses and its safety during …

Objective To assess the efficacy of systemic corticosteroids (CS) alone as first‐line treatment
in patients with Churg‐Strauss syndrome (CSS) without poor‐prognosis factors, as defined …

BACKGROUND: In some patients with Churg-Strauss syndrome (CSS), especially those
with myocardial or neural involvement, conventional treatment with corticosteroids with or …

Churg-Strauss syndrome (CSS) is a rare systemic disease characterized by necrotizing
vasculitis and peripheral eosinophilia. Cardiac involvement is considered common and is …

Churg-Strauss syndrome (CSS) is a rare necrotizing small-vessel vasculitis associated with
eosinophil-rich granulomatous inflammation of tissues and vessels and is also associated …